Your browser doesn't support javascript.
loading
Diffuse midline glioma invasion and metastasis rely on cell-autonomous signaling.
Bruschi, Marco; Midjek, Lilia; Ajlil, Yassine; Vairy, Stephanie; Lancien, Manon; Ghermaoui, Samia; Kergrohen, Thomas; Verreault, Maite; Idbaih, Ahmed; de Biagi, Carlos Alberto Oliveira; Liu, Ilon; Filbin, Mariella G; Beccaria, Kevin; Blauwblomme, Thomas; Puget, Stephanie; Tauziede-Espariat, Arnault; Varlet, Pascale; Dangouloff-Ros, Volodia; Boddaert, Nathalie; Le Teuff, Gwenael; Grill, Jacques; Montagnac, Guillaume; Elkhatib, Nadia; Debily, Marie-Anne; Castel, David.
Afiliação
  • Bruschi M; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Midjek L; Inserm U1279, Gustave Roussy Institute, Université Paris-Saclay, Villejuif, France.
  • Ajlil Y; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Vairy S; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Lancien M; Département de Cancérologie de l'Enfant et de l'Adolescent, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Ghermaoui S; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Kergrohen T; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Verreault M; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Idbaih A; Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, DMU Neurosciences, Service de Neurologie 2-Mazarin, Paris, France.
  • de Biagi CAO; Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, DMU Neurosciences, Service de Neurologie 2-Mazarin, Paris, France.
  • Liu I; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, USA.
  • Filbin MG; Broad Institute of MIT and Harvard, Cambridge, USA.
  • Beccaria K; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, USA.
  • Blauwblomme T; Broad Institute of MIT and Harvard, Cambridge, USA.
  • Puget S; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, USA.
  • Tauziede-Espariat A; Broad Institute of MIT and Harvard, Cambridge, USA.
  • Varlet P; Inserm U981, Molecular Predictors and New Targets in Oncology, Team Genomics and Oncogenesis of Pediatric Brain Tumors, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Dangouloff-Ros V; Department of Pediatric Neurosurgery, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.
  • Boddaert N; Department of Pediatric Neurosurgery, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.
  • Le Teuff G; Department of Pediatric Neurosurgery, Necker Enfants Malades Hospital, APHP, Université Paris Cité, Paris, France.
  • Grill J; Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, ParisFrance.
  • Montagnac G; Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR 1266, INSERM, IMA-BRAIN, Université de Paris, Paris, France.
  • Elkhatib N; Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, ParisFrance.
  • Debily MA; Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR 1266, INSERM, IMA-BRAIN, Université de Paris, Paris, France.
  • Castel D; Paediatric Radiology Department, AP-HP, Hôpital Necker Enfants Malades, Université Paris Cité, Institut Imagine INSERM U1163, ParisFrance.
Neuro Oncol ; 26(3): 553-568, 2024 03 04.
Article em En | MEDLINE | ID: mdl-37702430
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article